nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—type 2 diabetes mellitus—atherosclerosis	0.769	1	CtDrD
Glimepiride—CYP2C9—Rosuvastatin—atherosclerosis	0.032	0.267	CbGbCtD
Glimepiride—CYP2C9—Simvastatin—atherosclerosis	0.0298	0.248	CbGbCtD
Glimepiride—CYP2C9—Lovastatin—atherosclerosis	0.0292	0.243	CbGbCtD
Glimepiride—CYP2C9—Pravastatin—atherosclerosis	0.0292	0.243	CbGbCtD
Glimepiride—KCNJ1—appendage—atherosclerosis	0.00523	0.444	CbGeAlD
Glimepiride—ABCC8—penis—atherosclerosis	0.00452	0.383	CbGeAlD
Glimepiride—Glyburide—ABCA1—atherosclerosis	0.000872	0.326	CrCbGaD
Glimepiride—Gliclazide—VEGFA—atherosclerosis	0.000829	0.31	CrCbGaD
Glimepiride—KCNJ11—cardiovascular system—atherosclerosis	0.000789	0.0669	CbGeAlD
Glimepiride—ABCC8—cardiovascular system—atherosclerosis	0.000726	0.0616	CbGeAlD
Glimepiride—Vasculitis—Pravastatin—atherosclerosis	0.000715	0.00815	CcSEcCtD
Glimepiride—ABCC8—ABC-family proteins mediated transport—ABCG4—atherosclerosis	0.00071	0.0796	CbGpPWpGaD
Glimepiride—Hepatic function abnormal—Lovastatin—atherosclerosis	0.000685	0.00781	CcSEcCtD
Glimepiride—ABCC8—ABC-family proteins mediated transport—ABCG8—atherosclerosis	0.00068	0.0763	CbGpPWpGaD
Glimepiride—Hepatic failure—Lovastatin—atherosclerosis	0.000666	0.0076	CcSEcCtD
Glimepiride—Haemolytic anaemia—Lovastatin—atherosclerosis	0.000663	0.00756	CcSEcCtD
Glimepiride—Hepatic failure—Ezetimibe—atherosclerosis	0.000654	0.00745	CcSEcCtD
Glimepiride—Injury—Lovastatin—atherosclerosis	0.000652	0.00743	CcSEcCtD
Glimepiride—Diabetes mellitus—Simvastatin—atherosclerosis	0.000644	0.00734	CcSEcCtD
Glimepiride—Hepatic function abnormal—Simvastatin—atherosclerosis	0.000641	0.00731	CcSEcCtD
Glimepiride—Glipizide—PPARG—atherosclerosis	0.000638	0.238	CrCbGaD
Glimepiride—Hot flush—Ezetimibe—atherosclerosis	0.000628	0.00716	CcSEcCtD
Glimepiride—Hepatic failure—Simvastatin—atherosclerosis	0.000623	0.00711	CcSEcCtD
Glimepiride—Menopausal symptoms—Ezetimibe—atherosclerosis	0.000622	0.0071	CcSEcCtD
Glimepiride—Haemolytic anaemia—Simvastatin—atherosclerosis	0.00062	0.00708	CcSEcCtD
Glimepiride—Influenza—Rosuvastatin—atherosclerosis	0.000611	0.00697	CcSEcCtD
Glimepiride—Pain in extremity—Lovastatin—atherosclerosis	0.000599	0.00683	CcSEcCtD
Glimepiride—Diabetes mellitus—Niacin—atherosclerosis	0.000591	0.00674	CcSEcCtD
Glimepiride—Hepatic function abnormal—Niacin—atherosclerosis	0.000589	0.00671	CcSEcCtD
Glimepiride—Pain in extremity—Ezetimibe—atherosclerosis	0.000587	0.0067	CcSEcCtD
Glimepiride—Hepatic function abnormal—Pravastatin—atherosclerosis	0.000579	0.00661	CcSEcCtD
Glimepiride—Hepatic failure—Pravastatin—atherosclerosis	0.000564	0.00643	CcSEcCtD
Glimepiride—Haemolytic anaemia—Pravastatin—atherosclerosis	0.000561	0.0064	CcSEcCtD
Glimepiride—Injury—Pravastatin—atherosclerosis	0.000551	0.00628	CcSEcCtD
Glimepiride—Hot flush—Pravastatin—atherosclerosis	0.000541	0.00617	CcSEcCtD
Glimepiride—Dermatitis bullous—Niacin—atherosclerosis	0.000538	0.00614	CcSEcCtD
Glimepiride—ABCC8—ABC-family proteins mediated transport—ABCG1—atherosclerosis	0.000538	0.0603	CbGpPWpGaD
Glimepiride—Menopausal symptoms—Pravastatin—atherosclerosis	0.000537	0.00612	CcSEcCtD
Glimepiride—Jaundice—Rosuvastatin—atherosclerosis	0.000531	0.00605	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.000518	0.00591	CcSEcCtD
Glimepiride—Influenza—Lovastatin—atherosclerosis	0.000518	0.0059	CcSEcCtD
Glimepiride—Eosinophilia—Lovastatin—atherosclerosis	0.000512	0.00584	CcSEcCtD
Glimepiride—Influenza—Ezetimibe—atherosclerosis	0.000508	0.00579	CcSEcCtD
Glimepiride—Eosinophilia—Ezetimibe—atherosclerosis	0.000503	0.00573	CcSEcCtD
Glimepiride—Hepatitis—Rosuvastatin—atherosclerosis	0.000489	0.00558	CcSEcCtD
Glimepiride—Eosinophilia—Simvastatin—atherosclerosis	0.000479	0.00547	CcSEcCtD
Glimepiride—Photosensitivity reaction—Lovastatin—atherosclerosis	0.000472	0.00539	CcSEcCtD
Glimepiride—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.000463	0.00528	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000458	0.00522	CcSEcCtD
Glimepiride—Abdominal distension—Niacin—atherosclerosis	0.000448	0.0051	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.000447	0.00509	CcSEcCtD
Glimepiride—Influenza—Niacin—atherosclerosis	0.000445	0.00507	CcSEcCtD
Glimepiride—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000442	0.00504	CcSEcCtD
Glimepiride—Jaundice—Ezetimibe—atherosclerosis	0.000441	0.00503	CcSEcCtD
Glimepiride—Abdominal distension—Pravastatin—atherosclerosis	0.000441	0.00503	CcSEcCtD
Glimepiride—Influenza—Pravastatin—atherosclerosis	0.000438	0.00499	CcSEcCtD
Glimepiride—Arrhythmia—Rosuvastatin—atherosclerosis	0.000437	0.00498	CcSEcCtD
Glimepiride—Eosinophilia—Pravastatin—atherosclerosis	0.000433	0.00494	CcSEcCtD
Glimepiride—Angina pectoris—Niacin—atherosclerosis	0.000433	0.00494	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000428	0.00488	CcSEcCtD
Glimepiride—Angina pectoris—Pravastatin—atherosclerosis	0.000426	0.00486	CcSEcCtD
Glimepiride—Sweating increased—Pravastatin—atherosclerosis	0.000426	0.00486	CcSEcCtD
Glimepiride—ABCC8—ABC-family proteins mediated transport—ABCG5—atherosclerosis	0.000422	0.0474	CbGpPWpGaD
Glimepiride—Jaundice—Simvastatin—atherosclerosis	0.000421	0.0048	CcSEcCtD
Glimepiride—Hepatitis—Lovastatin—atherosclerosis	0.000414	0.00472	CcSEcCtD
Glimepiride—Hepatitis—Ezetimibe—atherosclerosis	0.000406	0.00463	CcSEcCtD
Glimepiride—Photosensitivity reaction—Pravastatin—atherosclerosis	0.0004	0.00456	CcSEcCtD
Glimepiride—Weight increased—Pravastatin—atherosclerosis	0.000398	0.00454	CcSEcCtD
Glimepiride—Erythema multiforme—Lovastatin—atherosclerosis	0.000392	0.00447	CcSEcCtD
Glimepiride—Angioedema—Rosuvastatin—atherosclerosis	0.000389	0.00443	CcSEcCtD
Glimepiride—Hepatitis—Simvastatin—atherosclerosis	0.000388	0.00442	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000387	0.00441	CcSEcCtD
Glimepiride—Jaundice—Niacin—atherosclerosis	0.000386	0.00441	CcSEcCtD
Glimepiride—Erythema multiforme—Ezetimibe—atherosclerosis	0.000384	0.00438	CcSEcCtD
Glimepiride—KCNJ11—Type II diabetes mellitus—ADIPOQ—atherosclerosis	0.000383	0.043	CbGpPWpGaD
Glimepiride—Jaundice—Pravastatin—atherosclerosis	0.00038	0.00434	CcSEcCtD
Glimepiride—Sweating—Niacin—atherosclerosis	0.00038	0.00433	CcSEcCtD
Glimepiride—Erythema multiforme—Simvastatin—atherosclerosis	0.000366	0.00418	CcSEcCtD
Glimepiride—Hepatitis—Niacin—atherosclerosis	0.000356	0.00406	CcSEcCtD
Glimepiride—Malnutrition—Ezetimibe—atherosclerosis	0.000354	0.00403	CcSEcCtD
Glimepiride—Erythema—Ezetimibe—atherosclerosis	0.000354	0.00403	CcSEcCtD
Glimepiride—Hepatitis—Pravastatin—atherosclerosis	0.00035	0.004	CcSEcCtD
Glimepiride—Confusional state—Rosuvastatin—atherosclerosis	0.00035	0.00399	CcSEcCtD
Glimepiride—Visual impairment—Niacin—atherosclerosis	0.000343	0.00391	CcSEcCtD
Glimepiride—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00034	0.00388	CcSEcCtD
Glimepiride—Vision blurred—Lovastatin—atherosclerosis	0.00034	0.00388	CcSEcCtD
Glimepiride—Tremor—Lovastatin—atherosclerosis	0.000338	0.00385	CcSEcCtD
Glimepiride—Visual impairment—Pravastatin—atherosclerosis	0.000338	0.00385	CcSEcCtD
Glimepiride—Erythema—Simvastatin—atherosclerosis	0.000337	0.00385	CcSEcCtD
Glimepiride—Erythema multiforme—Pravastatin—atherosclerosis	0.000331	0.00378	CcSEcCtD
Glimepiride—Angioedema—Lovastatin—atherosclerosis	0.00033	0.00376	CcSEcCtD
Glimepiride—Anaemia—Ezetimibe—atherosclerosis	0.000327	0.00373	CcSEcCtD
Glimepiride—CYP2C9—cardiovascular system—atherosclerosis	0.000325	0.0275	CbGeAlD
Glimepiride—Angioedema—Ezetimibe—atherosclerosis	0.000323	0.00369	CcSEcCtD
Glimepiride—Leukopenia—Lovastatin—atherosclerosis	0.000323	0.00368	CcSEcCtD
Glimepiride—Vision blurred—Simvastatin—atherosclerosis	0.000318	0.00363	CcSEcCtD
Glimepiride—Arrhythmia—Niacin—atherosclerosis	0.000318	0.00363	CcSEcCtD
Glimepiride—Tremor—Simvastatin—atherosclerosis	0.000316	0.0036	CcSEcCtD
Glimepiride—Insomnia—Rosuvastatin—atherosclerosis	0.000314	0.00358	CcSEcCtD
Glimepiride—Arrhythmia—Pravastatin—atherosclerosis	0.000313	0.00357	CcSEcCtD
Glimepiride—Palpitations—Ezetimibe—atherosclerosis	0.000313	0.00356	CcSEcCtD
Glimepiride—Paraesthesia—Rosuvastatin—atherosclerosis	0.000312	0.00356	CcSEcCtD
Glimepiride—Anaemia—Simvastatin—atherosclerosis	0.000312	0.00356	CcSEcCtD
Glimepiride—Malnutrition—Niacin—atherosclerosis	0.00031	0.00353	CcSEcCtD
Glimepiride—Erythema—Niacin—atherosclerosis	0.00031	0.00353	CcSEcCtD
Glimepiride—Angioedema—Simvastatin—atherosclerosis	0.000308	0.00352	CcSEcCtD
Glimepiride—Anxiety—Lovastatin—atherosclerosis	0.000306	0.00349	CcSEcCtD
Glimepiride—Dyspepsia—Rosuvastatin—atherosclerosis	0.000306	0.00349	CcSEcCtD
Glimepiride—Hypertension—Ezetimibe—atherosclerosis	0.000305	0.00348	CcSEcCtD
Glimepiride—Tension—Niacin—atherosclerosis	0.000304	0.00347	CcSEcCtD
Glimepiride—Leukopenia—Simvastatin—atherosclerosis	0.000302	0.00344	CcSEcCtD
Glimepiride—Nervousness—Niacin—atherosclerosis	0.000301	0.00343	CcSEcCtD
Glimepiride—Dry mouth—Lovastatin—atherosclerosis	0.0003	0.00342	CcSEcCtD
Glimepiride—Tension—Pravastatin—atherosclerosis	0.000299	0.00341	CcSEcCtD
Glimepiride—Confusional state—Lovastatin—atherosclerosis	0.000297	0.00338	CcSEcCtD
Glimepiride—Nervousness—Pravastatin—atherosclerosis	0.000296	0.00338	CcSEcCtD
Glimepiride—Dry mouth—Ezetimibe—atherosclerosis	0.000295	0.00336	CcSEcCtD
Glimepiride—Anaphylactic shock—Lovastatin—atherosclerosis	0.000294	0.00336	CcSEcCtD
Glimepiride—Vision blurred—Niacin—atherosclerosis	0.000292	0.00333	CcSEcCtD
Glimepiride—Confusional state—Ezetimibe—atherosclerosis	0.000291	0.00332	CcSEcCtD
Glimepiride—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000289	0.00329	CcSEcCtD
Glimepiride—Thrombocytopenia—Lovastatin—atherosclerosis	0.000288	0.00329	CcSEcCtD
Glimepiride—Vision blurred—Pravastatin—atherosclerosis	0.000287	0.00328	CcSEcCtD
Glimepiride—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000286	0.00326	CcSEcCtD
Glimepiride—Anxiety—Simvastatin—atherosclerosis	0.000286	0.00326	CcSEcCtD
Glimepiride—Tremor—Pravastatin—atherosclerosis	0.000286	0.00326	CcSEcCtD
Glimepiride—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000284	0.00324	CcSEcCtD
Glimepiride—Angioedema—Niacin—atherosclerosis	0.000283	0.00323	CcSEcCtD
Glimepiride—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000283	0.00322	CcSEcCtD
Glimepiride—Anaemia—Pravastatin—atherosclerosis	0.000282	0.00321	CcSEcCtD
Glimepiride—Anorexia—Lovastatin—atherosclerosis	0.000281	0.0032	CcSEcCtD
Glimepiride—Angioedema—Pravastatin—atherosclerosis	0.000279	0.00318	CcSEcCtD
Glimepiride—Confusional state—Simvastatin—atherosclerosis	0.000278	0.00317	CcSEcCtD
Glimepiride—Leukopenia—Niacin—atherosclerosis	0.000277	0.00316	CcSEcCtD
Glimepiride—Urticaria—Rosuvastatin—atherosclerosis	0.000276	0.00315	CcSEcCtD
Glimepiride—Anaphylactic shock—Simvastatin—atherosclerosis	0.000275	0.00314	CcSEcCtD
Glimepiride—Abdominal pain—Rosuvastatin—atherosclerosis	0.000275	0.00313	CcSEcCtD
Glimepiride—Palpitations—Niacin—atherosclerosis	0.000274	0.00312	CcSEcCtD
Glimepiride—Leukopenia—Pravastatin—atherosclerosis	0.000273	0.00311	CcSEcCtD
Glimepiride—Loss of consciousness—Niacin—atherosclerosis	0.000272	0.0031	CcSEcCtD
Glimepiride—Thrombocytopenia—Simvastatin—atherosclerosis	0.00027	0.00307	CcSEcCtD
Glimepiride—Insomnia—Lovastatin—atherosclerosis	0.000266	0.00304	CcSEcCtD
Glimepiride—Paraesthesia—Lovastatin—atherosclerosis	0.000264	0.00301	CcSEcCtD
Glimepiride—Hypertension—Pravastatin—atherosclerosis	0.000263	0.003	CcSEcCtD
Glimepiride—Anorexia—Simvastatin—atherosclerosis	0.000262	0.00299	CcSEcCtD
Glimepiride—Dyspnoea—Lovastatin—atherosclerosis	0.000262	0.00299	CcSEcCtD
Glimepiride—Insomnia—Ezetimibe—atherosclerosis	0.000261	0.00298	CcSEcCtD
Glimepiride—Paraesthesia—Ezetimibe—atherosclerosis	0.000259	0.00296	CcSEcCtD
Glimepiride—Dyspepsia—Lovastatin—atherosclerosis	0.000259	0.00295	CcSEcCtD
Glimepiride—Anxiety—Pravastatin—atherosclerosis	0.000259	0.00295	CcSEcCtD
Glimepiride—Dry mouth—Niacin—atherosclerosis	0.000258	0.00294	CcSEcCtD
Glimepiride—Dyspnoea—Ezetimibe—atherosclerosis	0.000257	0.00294	CcSEcCtD
Glimepiride—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000256	0.00292	CcSEcCtD
Glimepiride—Decreased appetite—Lovastatin—atherosclerosis	0.000256	0.00292	CcSEcCtD
Glimepiride—Dyspepsia—Ezetimibe—atherosclerosis	0.000254	0.0029	CcSEcCtD
Glimepiride—Fatigue—Lovastatin—atherosclerosis	0.000254	0.00289	CcSEcCtD
Glimepiride—Anaphylactic shock—Niacin—atherosclerosis	0.000253	0.00288	CcSEcCtD
Glimepiride—Confusional state—Pravastatin—atherosclerosis	0.000251	0.00286	CcSEcCtD
Glimepiride—Decreased appetite—Ezetimibe—atherosclerosis	0.000251	0.00286	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000249	0.00284	CcSEcCtD
Glimepiride—Asthenia—Rosuvastatin—atherosclerosis	0.000249	0.00284	CcSEcCtD
Glimepiride—Insomnia—Simvastatin—atherosclerosis	0.000249	0.00284	CcSEcCtD
Glimepiride—Anaphylactic shock—Pravastatin—atherosclerosis	0.000249	0.00284	CcSEcCtD
Glimepiride—Fatigue—Ezetimibe—atherosclerosis	0.000249	0.00284	CcSEcCtD
Glimepiride—Shock—Niacin—atherosclerosis	0.000249	0.00284	CcSEcCtD
Glimepiride—Paraesthesia—Simvastatin—atherosclerosis	0.000247	0.00282	CcSEcCtD
Glimepiride—Tachycardia—Niacin—atherosclerosis	0.000247	0.00281	CcSEcCtD
Glimepiride—Pruritus—Rosuvastatin—atherosclerosis	0.000246	0.0028	CcSEcCtD
Glimepiride—Dyspnoea—Simvastatin—atherosclerosis	0.000245	0.0028	CcSEcCtD
Glimepiride—Hyperhidrosis—Niacin—atherosclerosis	0.000244	0.00279	CcSEcCtD
Glimepiride—Thrombocytopenia—Pravastatin—atherosclerosis	0.000244	0.00278	CcSEcCtD
Glimepiride—Feeling abnormal—Lovastatin—atherosclerosis	0.000243	0.00277	CcSEcCtD
Glimepiride—Dyspepsia—Simvastatin—atherosclerosis	0.000242	0.00276	CcSEcCtD
Glimepiride—Anorexia—Niacin—atherosclerosis	0.000241	0.00275	CcSEcCtD
Glimepiride—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000241	0.00274	CcSEcCtD
Glimepiride—Hyperhidrosis—Pravastatin—atherosclerosis	0.000241	0.00274	CcSEcCtD
Glimepiride—Decreased appetite—Simvastatin—atherosclerosis	0.000239	0.00273	CcSEcCtD
Glimepiride—Feeling abnormal—Ezetimibe—atherosclerosis	0.000238	0.00271	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000238	0.00271	CcSEcCtD
Glimepiride—Diarrhoea—Rosuvastatin—atherosclerosis	0.000238	0.00271	CcSEcCtD
Glimepiride—Fatigue—Simvastatin—atherosclerosis	0.000237	0.00271	CcSEcCtD
Glimepiride—Anorexia—Pravastatin—atherosclerosis	0.000237	0.00271	CcSEcCtD
Glimepiride—Hypotension—Niacin—atherosclerosis	0.000236	0.00269	CcSEcCtD
Glimepiride—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000236	0.00269	CcSEcCtD
Glimepiride—Urticaria—Lovastatin—atherosclerosis	0.000234	0.00267	CcSEcCtD
Glimepiride—Abdominal pain—Lovastatin—atherosclerosis	0.000233	0.00265	CcSEcCtD
Glimepiride—Dizziness—Rosuvastatin—atherosclerosis	0.00023	0.00262	CcSEcCtD
Glimepiride—Urticaria—Ezetimibe—atherosclerosis	0.000229	0.00262	CcSEcCtD
Glimepiride—Insomnia—Niacin—atherosclerosis	0.000229	0.00261	CcSEcCtD
Glimepiride—Abdominal pain—Ezetimibe—atherosclerosis	0.000228	0.0026	CcSEcCtD
Glimepiride—Paraesthesia—Niacin—atherosclerosis	0.000227	0.00259	CcSEcCtD
Glimepiride—Feeling abnormal—Simvastatin—atherosclerosis	0.000227	0.00259	CcSEcCtD
Glimepiride—Dyspnoea—Niacin—atherosclerosis	0.000225	0.00257	CcSEcCtD
Glimepiride—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000225	0.00257	CcSEcCtD
Glimepiride—Insomnia—Pravastatin—atherosclerosis	0.000225	0.00257	CcSEcCtD
Glimepiride—Somnolence—Niacin—atherosclerosis	0.000225	0.00256	CcSEcCtD
Glimepiride—Paraesthesia—Pravastatin—atherosclerosis	0.000223	0.00255	CcSEcCtD
Glimepiride—Gliclazide—ALB—atherosclerosis	0.000223	0.0832	CrCbGaD
Glimepiride—Dyspepsia—Niacin—atherosclerosis	0.000223	0.00254	CcSEcCtD
Glimepiride—Dyspnoea—Pravastatin—atherosclerosis	0.000222	0.00253	CcSEcCtD
Glimepiride—Decreased appetite—Niacin—atherosclerosis	0.00022	0.00251	CcSEcCtD
Glimepiride—Dyspepsia—Pravastatin—atherosclerosis	0.000219	0.0025	CcSEcCtD
Glimepiride—Rash—Rosuvastatin—atherosclerosis	0.000219	0.0025	CcSEcCtD
Glimepiride—Dermatitis—Rosuvastatin—atherosclerosis	0.000219	0.0025	CcSEcCtD
Glimepiride—Urticaria—Simvastatin—atherosclerosis	0.000219	0.00249	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Niacin—atherosclerosis	0.000218	0.00249	CcSEcCtD
Glimepiride—Abdominal pain—Simvastatin—atherosclerosis	0.000218	0.00248	CcSEcCtD
Glimepiride—Headache—Rosuvastatin—atherosclerosis	0.000218	0.00248	CcSEcCtD
Glimepiride—Hypersensitivity—Lovastatin—atherosclerosis	0.000217	0.00247	CcSEcCtD
Glimepiride—Decreased appetite—Pravastatin—atherosclerosis	0.000216	0.00247	CcSEcCtD
Glimepiride—Fatigue—Pravastatin—atherosclerosis	0.000215	0.00245	CcSEcCtD
Glimepiride—Hypersensitivity—Ezetimibe—atherosclerosis	0.000213	0.00243	CcSEcCtD
Glimepiride—Asthenia—Lovastatin—atherosclerosis	0.000211	0.00241	CcSEcCtD
Glimepiride—Pruritus—Lovastatin—atherosclerosis	0.000208	0.00237	CcSEcCtD
Glimepiride—Asthenia—Ezetimibe—atherosclerosis	0.000207	0.00236	CcSEcCtD
Glimepiride—Gastrointestinal pain—Niacin—atherosclerosis	0.000207	0.00236	CcSEcCtD
Glimepiride—Nausea—Rosuvastatin—atherosclerosis	0.000206	0.00235	CcSEcCtD
Glimepiride—Feeling abnormal—Pravastatin—atherosclerosis	0.000205	0.00234	CcSEcCtD
Glimepiride—Pruritus—Ezetimibe—atherosclerosis	0.000204	0.00233	CcSEcCtD
Glimepiride—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000204	0.00232	CcSEcCtD
Glimepiride—Hypersensitivity—Simvastatin—atherosclerosis	0.000203	0.00231	CcSEcCtD
Glimepiride—Diarrhoea—Lovastatin—atherosclerosis	0.000201	0.0023	CcSEcCtD
Glimepiride—Urticaria—Niacin—atherosclerosis	0.000201	0.00229	CcSEcCtD
Glimepiride—CYP2C9—liver—atherosclerosis	0.000201	0.017	CbGeAlD
Glimepiride—Abdominal pain—Niacin—atherosclerosis	0.0002	0.00228	CcSEcCtD
Glimepiride—Urticaria—Pravastatin—atherosclerosis	0.000198	0.00225	CcSEcCtD
Glimepiride—Asthenia—Simvastatin—atherosclerosis	0.000198	0.00225	CcSEcCtD
Glimepiride—Diarrhoea—Ezetimibe—atherosclerosis	0.000198	0.00225	CcSEcCtD
Glimepiride—Abdominal pain—Pravastatin—atherosclerosis	0.000197	0.00224	CcSEcCtD
Glimepiride—Pruritus—Simvastatin—atherosclerosis	0.000195	0.00222	CcSEcCtD
Glimepiride—Dizziness—Lovastatin—atherosclerosis	0.000195	0.00222	CcSEcCtD
Glimepiride—Dizziness—Ezetimibe—atherosclerosis	0.000191	0.00218	CcSEcCtD
Glimepiride—Diarrhoea—Simvastatin—atherosclerosis	0.000188	0.00215	CcSEcCtD
Glimepiride—Vomiting—Lovastatin—atherosclerosis	0.000187	0.00213	CcSEcCtD
Glimepiride—Hypersensitivity—Niacin—atherosclerosis	0.000186	0.00212	CcSEcCtD
Glimepiride—Rash—Lovastatin—atherosclerosis	0.000186	0.00212	CcSEcCtD
Glimepiride—Dermatitis—Lovastatin—atherosclerosis	0.000185	0.00211	CcSEcCtD
Glimepiride—Headache—Lovastatin—atherosclerosis	0.000184	0.0021	CcSEcCtD
Glimepiride—Vomiting—Ezetimibe—atherosclerosis	0.000184	0.00209	CcSEcCtD
Glimepiride—Hypersensitivity—Pravastatin—atherosclerosis	0.000183	0.00209	CcSEcCtD
Glimepiride—Dizziness—Simvastatin—atherosclerosis	0.000182	0.00208	CcSEcCtD
Glimepiride—Rash—Ezetimibe—atherosclerosis	0.000182	0.00208	CcSEcCtD
Glimepiride—Dermatitis—Ezetimibe—atherosclerosis	0.000182	0.00207	CcSEcCtD
Glimepiride—Asthenia—Niacin—atherosclerosis	0.000181	0.00207	CcSEcCtD
Glimepiride—Headache—Ezetimibe—atherosclerosis	0.000181	0.00206	CcSEcCtD
Glimepiride—Pruritus—Niacin—atherosclerosis	0.000179	0.00204	CcSEcCtD
Glimepiride—Asthenia—Pravastatin—atherosclerosis	0.000179	0.00204	CcSEcCtD
Glimepiride—Pruritus—Pravastatin—atherosclerosis	0.000176	0.00201	CcSEcCtD
Glimepiride—Vomiting—Simvastatin—atherosclerosis	0.000175	0.002	CcSEcCtD
Glimepiride—Nausea—Lovastatin—atherosclerosis	0.000175	0.00199	CcSEcCtD
Glimepiride—Rash—Simvastatin—atherosclerosis	0.000174	0.00198	CcSEcCtD
Glimepiride—Dermatitis—Simvastatin—atherosclerosis	0.000173	0.00198	CcSEcCtD
Glimepiride—Diarrhoea—Niacin—atherosclerosis	0.000173	0.00197	CcSEcCtD
Glimepiride—Headache—Simvastatin—atherosclerosis	0.000172	0.00197	CcSEcCtD
Glimepiride—Nausea—Ezetimibe—atherosclerosis	0.000171	0.00196	CcSEcCtD
Glimepiride—Diarrhoea—Pravastatin—atherosclerosis	0.00017	0.00194	CcSEcCtD
Glimepiride—Dizziness—Niacin—atherosclerosis	0.000167	0.00191	CcSEcCtD
Glimepiride—Dizziness—Pravastatin—atherosclerosis	0.000165	0.00188	CcSEcCtD
Glimepiride—ABCC8—ABC-family proteins mediated transport—APOA1—atherosclerosis	0.000164	0.0184	CbGpPWpGaD
Glimepiride—Nausea—Simvastatin—atherosclerosis	0.000164	0.00186	CcSEcCtD
Glimepiride—Vomiting—Niacin—atherosclerosis	0.000161	0.00183	CcSEcCtD
Glimepiride—Rash—Niacin—atherosclerosis	0.000159	0.00182	CcSEcCtD
Glimepiride—Dermatitis—Niacin—atherosclerosis	0.000159	0.00182	CcSEcCtD
Glimepiride—Headache—Niacin—atherosclerosis	0.000158	0.00181	CcSEcCtD
Glimepiride—Vomiting—Pravastatin—atherosclerosis	0.000158	0.0018	CcSEcCtD
Glimepiride—Rash—Pravastatin—atherosclerosis	0.000157	0.00179	CcSEcCtD
Glimepiride—Dermatitis—Pravastatin—atherosclerosis	0.000157	0.00179	CcSEcCtD
Glimepiride—Headache—Pravastatin—atherosclerosis	0.000156	0.00178	CcSEcCtD
Glimepiride—Nausea—Niacin—atherosclerosis	0.00015	0.00171	CcSEcCtD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.000149	0.0167	CbGpPWpGaD
Glimepiride—Nausea—Pravastatin—atherosclerosis	0.000148	0.00169	CcSEcCtD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—APOA1—atherosclerosis	0.000139	0.0156	CbGpPWpGaD
Glimepiride—KCNJ11—Type II diabetes mellitus—MAPK8—atherosclerosis	0.000139	0.0156	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—LTA4H—atherosclerosis	0.000138	0.0155	CbGpPWpGaD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—APOA1—atherosclerosis	0.000135	0.0152	CbGpPWpGaD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000135	0.0151	CbGpPWpGaD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—F2—atherosclerosis	0.000133	0.0149	CbGpPWpGaD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—F2—atherosclerosis	0.000129	0.0145	CbGpPWpGaD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—INS—atherosclerosis	0.000121	0.0135	CbGpPWpGaD
Glimepiride—Glyburide—ALB—atherosclerosis	0.000117	0.0437	CrCbGaD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—INS—atherosclerosis	0.000117	0.0131	CbGpPWpGaD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000117	0.0131	CbGpPWpGaD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—ALB—atherosclerosis	0.00011	0.0124	CbGpPWpGaD
Glimepiride—KCNJ11—Type II diabetes mellitus—TNF—atherosclerosis	0.00011	0.0124	CbGpPWpGaD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—atherosclerosis	0.000107	0.012	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—ALOX15—atherosclerosis	8.67e-05	0.00973	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—ALOX5AP—atherosclerosis	8.67e-05	0.00973	CbGpPWpGaD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	8.55e-05	0.0096	CbGpPWpGaD
Glimepiride—CYP2C9—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	8.44e-05	0.00947	CbGpPWpGaD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	7.9e-05	0.00887	CbGpPWpGaD
Glimepiride—CYP2C9—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	7.8e-05	0.00875	CbGpPWpGaD
Glimepiride—ABCC8—Regulation of insulin secretion—INS—atherosclerosis	7.7e-05	0.00864	CbGpPWpGaD
Glimepiride—KCNJ11—Regulation of insulin secretion—INS—atherosclerosis	7.47e-05	0.00838	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ABCG4—atherosclerosis	7.41e-05	0.00832	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—ALOX5—atherosclerosis	7.37e-05	0.00827	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—PRKCG—atherosclerosis	7.31e-05	0.0082	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ABCG8—atherosclerosis	7.11e-05	0.00798	CbGpPWpGaD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	6.96e-05	0.00781	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	6.93e-05	0.00778	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	6.41e-05	0.00719	CbGpPWpGaD
Glimepiride—ABCC8—Integration of energy metabolism—INS—atherosclerosis	6.06e-05	0.0068	CbGpPWpGaD
Glimepiride—KCNJ11—Integration of energy metabolism—INS—atherosclerosis	5.87e-05	0.00659	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ABCG1—atherosclerosis	5.62e-05	0.00631	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	5.09e-05	0.00572	CbGpPWpGaD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	4.86e-05	0.00545	CbGpPWpGaD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	4.82e-05	0.00541	CbGpPWpGaD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	4.71e-05	0.00529	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—TRPV1—atherosclerosis	4.58e-05	0.00514	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ABCG5—atherosclerosis	4.41e-05	0.00495	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—LDLRAP1—atherosclerosis	4.08e-05	0.00458	CbGpPWpGaD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	3.99e-05	0.00447	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—LDLRAP1—atherosclerosis	3.96e-05	0.00444	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—GPX1—atherosclerosis	3.91e-05	0.00439	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PLTP—atherosclerosis	3.84e-05	0.00431	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—PRKCG—atherosclerosis	3.73e-05	0.00419	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PLTP—atherosclerosis	3.72e-05	0.00418	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—CYP7A1—atherosclerosis	3.68e-05	0.00413	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP7A1—atherosclerosis	3.63e-05	0.00408	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—PRKCG—atherosclerosis	3.62e-05	0.00406	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—CYP27A1—atherosclerosis	3.4e-05	0.00382	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP27A1—atherosclerosis	3.36e-05	0.00377	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ABCG8—atherosclerosis	3.33e-05	0.00374	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—LTA4H—atherosclerosis	3.33e-05	0.00374	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—CETP—atherosclerosis	3.26e-05	0.00366	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—LTA4H—atherosclerosis	3.23e-05	0.00362	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ABCG8—atherosclerosis	3.23e-05	0.00362	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—PLAT—atherosclerosis	2.88e-05	0.00323	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ABCG1—atherosclerosis	2.63e-05	0.00295	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ABCG1—atherosclerosis	2.55e-05	0.00286	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—FABP4—atherosclerosis	2.47e-05	0.00278	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—LCAT—atherosclerosis	2.47e-05	0.00278	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—PLG—atherosclerosis	2.45e-05	0.00274	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—APOA4—atherosclerosis	2.43e-05	0.00273	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	2.42e-05	0.00272	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—FABP4—atherosclerosis	2.4e-05	0.00269	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—LCAT—atherosclerosis	2.4e-05	0.00269	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP7A1—atherosclerosis	2.39e-05	0.00268	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—APOA4—atherosclerosis	2.36e-05	0.00264	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP7A1—atherosclerosis	2.31e-05	0.0026	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—PTGS2—atherosclerosis	2.3e-05	0.00258	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	2.28e-05	0.00255	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.26e-05	0.00253	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP27A1—atherosclerosis	2.21e-05	0.00247	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—APOB—atherosclerosis	2.16e-05	0.00243	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP27A1—atherosclerosis	2.14e-05	0.0024	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ALOX15—atherosclerosis	2.09e-05	0.00235	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PLA2G2A—atherosclerosis	2.09e-05	0.00235	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—APOA2—atherosclerosis	2.09e-05	0.00235	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ALOX5AP—atherosclerosis	2.09e-05	0.00235	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ABCG5—atherosclerosis	2.07e-05	0.00232	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—APOA2—atherosclerosis	2.03e-05	0.00228	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ALOX5AP—atherosclerosis	2.03e-05	0.00228	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ALOX15—atherosclerosis	2.03e-05	0.00228	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PLA2G2A—atherosclerosis	2.03e-05	0.00228	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ABCG5—atherosclerosis	2e-05	0.00225	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—LPA—atherosclerosis	1.99e-05	0.00224	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	1.97e-05	0.00221	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	1.97e-05	0.00221	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—LPA—atherosclerosis	1.93e-05	0.00217	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—BGN—atherosclerosis	1.93e-05	0.00217	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—APOA5—atherosclerosis	1.91e-05	0.00215	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—BGN—atherosclerosis	1.87e-05	0.0021	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—APOA5—atherosclerosis	1.85e-05	0.00208	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PLA2G1B—atherosclerosis	1.84e-05	0.00207	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.82e-05	0.00205	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PLA2G1B—atherosclerosis	1.79e-05	0.002	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ALOX5—atherosclerosis	1.78e-05	0.00199	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ALOX5—atherosclerosis	1.72e-05	0.00193	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.71e-05	0.00192	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NAMPT—atherosclerosis	1.59e-05	0.00179	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—LIPC—atherosclerosis	1.58e-05	0.00178	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—APOC3—atherosclerosis	1.57e-05	0.00177	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—LDLR—atherosclerosis	1.57e-05	0.00176	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	1.56e-05	0.00175	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NAMPT—atherosclerosis	1.55e-05	0.00174	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—LIPC—atherosclerosis	1.54e-05	0.00172	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CETP—atherosclerosis	1.53e-05	0.00172	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—APOC3—atherosclerosis	1.53e-05	0.00171	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GSTM1—atherosclerosis	1.52e-05	0.00171	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—LDLR—atherosclerosis	1.52e-05	0.0017	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—GSTM1—atherosclerosis	1.5e-05	0.00168	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CETP—atherosclerosis	1.48e-05	0.00166	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	1.47e-05	0.00165	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	1.47e-05	0.00165	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SCARB1—atherosclerosis	1.46e-05	0.00164	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	1.44e-05	0.00162	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SCARB1—atherosclerosis	1.42e-05	0.00159	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	1.41e-05	0.00159	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HMGCR—atherosclerosis	1.38e-05	0.00155	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ALB—atherosclerosis	1.36e-05	0.00152	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HMGCR—atherosclerosis	1.34e-05	0.0015	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	1.31e-05	0.00147	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	1.24e-05	0.00139	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	1.24e-05	0.00139	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	1.24e-05	0.00139	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	1.24e-05	0.00139	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ABCA1—atherosclerosis	1.23e-05	0.00138	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	1.22e-05	0.00137	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ABCA1—atherosclerosis	1.19e-05	0.00134	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	1.18e-05	0.00133	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	1.13e-05	0.00127	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	1.09e-05	0.00122	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	1.08e-05	0.00121	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HMOX1—atherosclerosis	1.06e-05	0.00119	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	1.05e-05	0.00118	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HMOX1—atherosclerosis	1.03e-05	0.00115	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PLTP—atherosclerosis	1.01e-05	0.00114	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—APOB—atherosclerosis	1.01e-05	0.00114	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTM1—atherosclerosis	9.85e-06	0.00111	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—APOB—atherosclerosis	9.82e-06	0.0011	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—LPL—atherosclerosis	9.67e-06	0.00109	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTM1—atherosclerosis	9.55e-06	0.00107	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GPX1—atherosclerosis	9.43e-06	0.00106	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	9.39e-06	0.00105	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—LPL—atherosclerosis	9.38e-06	0.00105	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	9.33e-06	0.00105	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	9.28e-06	0.00104	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CD36—atherosclerosis	9.19e-06	0.00103	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GPX1—atherosclerosis	9.15e-06	0.00103	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	9.06e-06	0.00102	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CD36—atherosclerosis	8.91e-06	0.001	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCG8—atherosclerosis	8.79e-06	0.000986	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LTA4H—atherosclerosis	8.79e-06	0.000986	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—MTHFR—atherosclerosis	8.71e-06	0.000977	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	8.68e-06	0.000974	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PPARA—atherosclerosis	8.54e-06	0.000958	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—MTHFR—atherosclerosis	8.44e-06	0.000947	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PPARA—atherosclerosis	8.28e-06	0.000929	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AGT—atherosclerosis	8.27e-06	0.000928	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	8.19e-06	0.000919	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—APOE—atherosclerosis	8.11e-06	0.00091	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CAV1—atherosclerosis	8.03e-06	0.000901	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AGT—atherosclerosis	8.02e-06	0.0009	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—APOA1—atherosclerosis	8.01e-06	0.000899	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—APOE—atherosclerosis	7.86e-06	0.000882	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CAV1—atherosclerosis	7.79e-06	0.000874	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—APOA1—atherosclerosis	7.77e-06	0.000872	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CG—atherosclerosis	7.32e-06	0.000821	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	7.3e-06	0.000819	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CG—atherosclerosis	7.09e-06	0.000796	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PPARG—atherosclerosis	7.06e-06	0.000792	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCG1—atherosclerosis	6.95e-06	0.000779	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—INS—atherosclerosis	6.92e-06	0.000777	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PPARG—atherosclerosis	6.85e-06	0.000768	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—INS—atherosclerosis	6.71e-06	0.000753	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—FABP4—atherosclerosis	6.53e-06	0.000733	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LCAT—atherosclerosis	6.53e-06	0.000733	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APOA4—atherosclerosis	6.41e-06	0.000719	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ALB—atherosclerosis	6.35e-06	0.000712	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP7A1—atherosclerosis	6.3e-06	0.000707	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ALB—atherosclerosis	6.16e-06	0.000691	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NOS3—atherosclerosis	6.07e-06	0.000681	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	6e-06	0.000673	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NOS3—atherosclerosis	5.89e-06	0.000661	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP27A1—atherosclerosis	5.82e-06	0.000653	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	5.73e-06	0.000643	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	5.59e-06	0.000627	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PTGS2—atherosclerosis	5.55e-06	0.000623	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	5.52e-06	0.000619	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APOA2—atherosclerosis	5.52e-06	0.000619	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALOX15—atherosclerosis	5.52e-06	0.000619	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	5.52e-06	0.000619	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCG5—atherosclerosis	5.45e-06	0.000612	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	5.44e-06	0.000611	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PTGS2—atherosclerosis	5.39e-06	0.000604	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LPA—atherosclerosis	5.26e-06	0.000591	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—BGN—atherosclerosis	5.1e-06	0.000572	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	5.06e-06	0.000568	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APOA5—atherosclerosis	5.05e-06	0.000566	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	4.9e-06	0.00055	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	4.86e-06	0.000545	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	4.8e-06	0.000539	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	4.76e-06	0.000534	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	4.75e-06	0.000533	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALOX5—atherosclerosis	4.69e-06	0.000527	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.34e-06	0.000486	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NAMPT—atherosclerosis	4.21e-06	0.000472	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.18e-06	0.000469	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LIPC—atherosclerosis	4.18e-06	0.000469	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APOC3—atherosclerosis	4.16e-06	0.000466	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LDLR—atherosclerosis	4.13e-06	0.000464	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CETP—atherosclerosis	4.03e-06	0.000453	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SCARB1—atherosclerosis	3.86e-06	0.000434	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.76e-06	0.000422	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HMGCR—atherosclerosis	3.65e-06	0.000409	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.29e-06	0.000369	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCA1—atherosclerosis	3.25e-06	0.000365	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AKT1—atherosclerosis	2.79e-06	0.000313	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HMOX1—atherosclerosis	2.79e-06	0.000313	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AKT1—atherosclerosis	2.71e-06	0.000304	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APOB—atherosclerosis	2.67e-06	0.0003	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTM1—atherosclerosis	2.6e-06	0.000292	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LPL—atherosclerosis	2.55e-06	0.000286	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GPX1—atherosclerosis	2.49e-06	0.000279	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CD36—atherosclerosis	2.42e-06	0.000272	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—MTHFR—atherosclerosis	2.3e-06	0.000258	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PPARA—atherosclerosis	2.25e-06	0.000253	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AGT—atherosclerosis	2.18e-06	0.000245	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APOE—atherosclerosis	2.14e-06	0.00024	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CAV1—atherosclerosis	2.12e-06	0.000238	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APOA1—atherosclerosis	2.11e-06	0.000237	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CG—atherosclerosis	1.93e-06	0.000217	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PPARG—atherosclerosis	1.86e-06	0.000209	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—INS—atherosclerosis	1.83e-06	0.000205	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALB—atherosclerosis	1.68e-06	0.000188	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NOS3—atherosclerosis	1.6e-06	0.00018	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.47e-06	0.000164	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AKT1—atherosclerosis	7.37e-07	8.27e-05	CbGpPWpGaD
